Beneficial Antiarrhythmic Effect of Beta-blockade in Patients with Dilated Cardiomyopathy : CURRENT THERAPY OF INTRACTABLE HEART FAILURE
1992 年 56 巻 1 号 p. 77-85
詳細
1992 年 56 巻 1 号 p. 77-85
Antiarrhythmic effects of beta-blockade (BB) in patients with dilated cardiomyopathy were compared with those of various antiarrhythmic agents using ambulatory Holter monitoring. The BB therapy effectively suppressed ventricular extrasystoles (VEs) in 85% of patients, as evidenced by improvement in Lown's grade or a reduction in the number of the highest grade Ves<50%. In contrast, conventional antiarrhythmic agents, except flecainaid and amiodarone, were poorly effective in suppressing VEs. BB therapy gradually increased left ventricular fractional shortening (16±6% to 22±12%) and improved 12-month survival rates as compared with those receiving conventional therapy (93 vs 69%). This antiarrhythmic potency seemed to be an additional therapeutic efficacy of BB in the management of patients with dilated cardiomyopathy, which frequently associated with serious VEs.
